Summit Therapeutics Inc (NAS:SMMT)
$ 17.77 -0.72 (-3.89%) Market Cap: 13.10 Bil Enterprise Value: 13.18 Bil PE Ratio: 0 PB Ratio: 30.12 GF Score: 30/100